Product NDC: | 55154-6950 |
Proprietary Name: | Lidocaine Hydrochloride and Epinephrine |
Non Proprietary Name: | lidocaine hydrochloride anhydrous and epinephrine |
Active Ingredient(s): | 10; 20 ug/mL; mg/mL & nbsp; lidocaine hydrochloride anhydrous and epinephrine |
Administration Route(s): | INFILTRATION |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-6950 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089646 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100405 |
Package NDC: | 55154-6950-8 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (55154-6950-8) > 20 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 55154-6950-8 |
Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (55154-6950-8) > 20 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 55154-6950 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lidocaine hydrochloride anhydrous and epinephrine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INFILTRATION |
Start Marketing Date | 20100405 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
Strength Number | 10; 20 |
Strength Unit | ug/mL; mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |